Clinical Trials - malecare.org

Yale Researchers Present Results of Phase II Phenoxodiol Clinical Trial in Prostate Cancer Patients at ASCO 2009 Genitourinary Cancers Symposium

Marshall Edwards, Inc. (NASDAQ: MSHL) is planning to release preliminary results from a Phase II clinical trial of oral phenoxodiol in patients with early and advanced stage prostate cancer. The results will be presented by the Yale researchers, who were responsible for the study, at the ASCO Genitourinary Cancers Symposium in Orlando, Florida; February 26-28, [...]

By Malecare|2017-10-19T10:56:04-04:00February 25th, 2009|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Research, Uncategorized|0 Comments

A Possible Surrogate Endpoint- Circulating Tumor Cells

There is nothing more frustration that the current methods used by the FDA to approve drugs. The theory is great, but how it gets translated into our real world is killer, I mean a literal killer of men. The FDA wants assurances that before they approve a drug that it really works, or shows efficacy. [...]

By Malecare|2020-02-04T10:39:49-05:00February 12th, 2009|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Research, Uncategorized, Understanding APC|0 Comments

Cougar Biotech and the FDA Agree on new Abiraterone Trial

An announcement from Market Watch claims that Cougar Biotechnology has come to an agreement with the US Food & Drug Administration (FDA) to conduct an additional Phase III trial of abiraterone acetate in prostate cancer. The currently ongoing and much in demand Phase III trial of abiraterone acetate was designed for prostate cancer survivors who [...]

By Malecare|2017-10-19T10:56:10-04:00February 11th, 2009|Advanced Prostate Cancer, Chemo Therapy, Clinical Trials, Clinical Trials, Uncategorized|3 Comments

Lycopene – Just Another Bust!

A group of investigators, interested in the influence of lycopene on both the clinical and laboratory progression of advanced prostate cancer in men with hormone refractory prostate cancer, ran a small prospective Phase II pilot study. The researchers gave lycopene supplementation (15 mg) daily for 6 months to their trial subjects. They performed follow up [...]

By Malecare|2017-10-19T10:56:11-04:00February 10th, 2009|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Diet and Supplements, Germany, Uncategorized, Understanding APC|0 Comments

Additional Information On Yesterday’s Post About Alpharadin

Charles (Chuck) Maack, Prostate Cancer Advocate/Mentor from the Wichita Kansas Chapter of Us TOO sent me this follow-up to yesterday's post on Alpharadin. Interesting is this drug completed Phase II trials in Norway back in October 2007 involving 64 HRPC patients with more than twice as many patients receiving Alpharadin alive (10 of 33) two [...]

By Malecare|2021-02-17T10:45:33-05:00February 5th, 2009|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Metastases, Uncategorized|0 Comments